Arbutus Biopharma
ABUS
$2.71
Share price
1.12%
Change (1 day)
6.27%
Change (1 year)
Categories
Operating Margin for Arbutus Biopharma (ABUS)
Operating Margin as of May 2024 (TTM): -211.41%
According to Arbutus Biopharma 's latest financial reports and stock price the company's current Operating Margin is -211.41%. At the end of 2021 the company had an Operating Margin of -693.91%.
Operating Margin history for Arbutus Biopharma from 2008 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -693.91% | -24.74% |
| 2020 | -921.97% | -66.69% |
| 2019 | -2,767.91% | 168.25% |
| 2018 | -1,031.83% | 1.54% |
| 2017 | -1,016.20% | -96.9% |
| 2016 | -32,807.91% | 10455.86% |
| 2015 | -310.80% | 19.67% |
| 2014 | -259.73% | 185.58% |
| 2013 | -90.95% | -143.06% |
| 2012 | 211.19% | -433.55% |
| 2011 | -63.32% | 8.03% |
| 2010 | -58.61% | -10.92% |
| 2009 | -65.79% | -45.88% |
| 2008 | -121.56% | 649.5% |
| 2007 | -16.22% | -112.21% |
| 2006 | 132.89% | -330.24% |
| 2005 | -57.72% | -69.96% |
| 2004 | -192.13% | -84.85% |
| 2003 | -1,268.10% | 132.06% |
| 2002 | -546.46% | 15.19% |
| 2001 | -474.40% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -234,760.00% | 110,944.89% | Bahamas |
 NRC Health
NRC | 32.86% | -115.54% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.